Egypt

BMI View: Predicting the exact outcome of the popular protests in the Middle East and North Africa (MENA) is impossible at this stage. However, BMI does envisage a probable scenario... 2011-05-20

BMI View: Predicting the exact outcome of the current popular protests in the Middle East and North Africa (MENA) is impossible at this stage. However, BMI envisages a probable scenario... 2011-05-13

BMI View: Egypt's pharmaceutical market has not yet been fundamentally changed by the political upheaval. If anything, 2011 is likely to be a year in which the industry sees very little... 2011-04-19

BMI View: Political instability in Egypt was not as protracted or damaging to pharmaceutical sales as BMI had first feared. In the wake of the crisis, with the army enforcing relative... 2011-04-14

BMI View: Saudi Arabia represents a leading opportunity for foreign drugmakers operating in the Middle East. Underpinned by relative political stability and a stable economy, the country's... 2011-02-17

BMI View: Forecasts of pharmaceutical sales and healthcare expenditure have been revised downwards in response to the popular uprising in Egypt. This forecast is a snapshot of the possible... 2011-02-04

BMI View: Forecasts of pharmaceutical sales and healthcare expenditure have been revised downwards in response to the popular uprising in Egypt. This forecast is a snapshot of the possible... 2011-02-04

BMI View: Egypt needs reforms to its regulatory framework to make it easier for drugs to be registered and reduce corruption. However, the proposed reform to the country?s medicine... 2010-11-08

BMI View: Multinational pharmaceutical companies will partner with local sales and marketing firms based in emerging markets to increase the market penetration of their medicines. By... 2010-10-06

In late 2009, BMI analysed the drug pricing amendment put forward by the Egyptian government. The implications for the local and multinational drugmakers in the country were far-reaching... 2010-05-14